Neurocrine Biosciences, Inc. (FRA:NB3)

Neurocrine Biosciences Statistics

Total Valuation

FRA:NB3 has a market cap or net worth of EUR 10.96 billion. The enterprise value is 10.10 billion.

Market Cap	10.96B
Enterprise Value	10.10B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	100.36M
Shares Outstanding	n/a
Shares Change (YoY)	-1.16%
Shares Change (QoQ)	+1.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	99.07M

Valuation Ratios

The trailing PE ratio is 26.88 and the forward PE ratio is 15.46.

PE Ratio	26.88
Forward PE	15.46
PS Ratio	4.50
PB Ratio	3.95
P/TBV Ratio	3.95
P/FCF Ratio	17.18
P/OCF Ratio	16.44
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.35, with an EV/FCF ratio of 15.84.

EV / Earnings	24.78
EV / Sales	4.16
EV / EBITDA	16.35
EV / EBIT	18.70
EV / FCF	15.84

Financial Position

The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.14.

Current Ratio	3.39
Quick Ratio	2.92
Debt / Equity	0.14
Debt / EBITDA	0.65
Debt / FCF	0.63
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.38% and return on invested capital (ROIC) is 18.73%.

Return on Equity (ROE)	16.38%
Return on Assets (ROA)	9.53%
Return on Invested Capital (ROIC)	18.73%
Return on Capital Employed (ROCE)	16.37%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.22M
Profits Per Employee	203,812
Employee Count	2,000
Asset Turnover	0.69
Inventory Turnover	16.90

Taxes

In the past 12 months, FRA:NB3 has paid 193.17 million in taxes.

Income Tax	193.17M
Effective Tax Rate	32.15%

Stock Price Statistics

The stock price has increased by +0.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.78%
50-Day Moving Average	117.38
200-Day Moving Average	116.18
Relative Strength Index (RSI)	44.32
Average Volume (20 Days)	25

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.96

Income Statement

In the last 12 months, FRA:NB3 had revenue of EUR 2.44 billion and earned 407.62 million in profits. Earnings per share was 3.98.

Revenue	2.44B
Gross Profit	1.53B
Operating Income	542.11M
Pretax Income	600.79M
Net Income	407.62M
EBITDA	567.74M
EBIT	542.11M
Earnings Per Share (EPS)	3.98

Balance Sheet

The company has 1.26 billion in cash and 401.41 million in debt, with a net cash position of 859.45 million.

Cash & Cash Equivalents	1.26B
Total Debt	401.41M
Net Cash	859.45M
Net Cash Per Share	n/a
Equity (Book Value)	2.77B
Book Value Per Share	27.68
Working Capital	1.52B

Cash Flow

In the last 12 months, operating cash flow was 666.63 million and capital expenditures -28.96 million, giving a free cash flow of 637.67 million.

Operating Cash Flow	666.63M
Capital Expenditures	-28.96M
Free Cash Flow	637.67M
FCF Per Share	n/a

Margins

Gross margin is 62.67%, with operating and profit margins of 22.25% and 16.73%.

Gross Margin	62.67%
Operating Margin	22.25%
Pretax Margin	24.66%
Profit Margin	16.73%
EBITDA Margin	23.30%
EBIT Margin	22.25%
FCF Margin	26.17%

Dividends & Yields

FRA:NB3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.16%
Shareholder Yield	1.16%
Earnings Yield	3.72%
FCF Yield	5.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:NB3 has an Altman Z-Score of 7.33 and a Piotroski F-Score of 5.

Altman Z-Score	7.33
Piotroski F-Score	5